Fairmount Funds Management LLC declares 20.0% of Mentari Therapeutics
Fairmount Funds Management LLC told the SEC on November 12 that it holds 20.0% of Mentari Therapeutics, and it did not file as a passive investor.
The filing
13D
19.99%
Of the shares
-
Value
Active
Investor
M
Mentari Therapeutics, Inc. Common Stock
Holds 10,555,507 shares
Declared to the SEC, the US stock market watchdog (Schedule 13D), after the 5% threshold was crossed on November 6, filed on November 12.